Archive
07.02.2012 JSC «Grindeks» informs that the Company takes part in two EU-funded competence centres – “Pharma and Chemistry Competence Centre” and “Environment, Bioenergetics and Biotechnology Competence Centre”. «Grindeks»: currently we have 20 new products under development 06.02.2012 «Grindeks» informs that it is currently developing 20 new products. Among these are the new combinations of Mildronate® and generics. Juris Bundulis appointed as Chairman of the Board of JSC «Grindeks» 09.01.2012
|
||||||||||||||||||||||||||

